Zaid Muslim

Zaid Muslim

Auto-generated profile, based on publicly available information

Zaid Muslim

Division of Thoracic Surgery, Rudy L. Ruggles Biomedical Research Institute, Danbury, CT, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2022 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
MBMirza Zain Baig
Mirza Zain Baig
SRSyed S Razi
Syed S Razi
KAKojo Agyabeng-Dadzie
Kojo Agyabeng-Dadzie
SSStephanie Stroever
Stephanie Stroever
ZMZaid Muslim
Zaid Muslim
FBFaiz Y Bhora
Faiz Y Bhora
OBJECTIVES: Locally advanced lung cancers present a significant challenge to minimally invasive thoracic surgeons. An increasing number of centres have adopted robotic-assisted thoracoscopic surgeries for these complex operations. In this study, we compare surgical margins achieved, conversion rates to thoracotomy, perioperative mortality and 30-day readmission rates for robotic and video-assisted thoracoscopic surgery (VATS) lobectomy for locally advanced lung cancers. METHODS: Using the National Cancer Database, we identified patients with non-small-cell lung cancer who received neoadjuvant chemotherapy/radiotherapy, had clinical N1/N2 disease or in the absence of these 2 features had a tumour >5 cm treated with either robotic or VATS lobectomy between 2010 and 2016. Perioperative outcomes and conversion rates were compared between robotic and VATS lobectomy. RESULTS: A total of 9512 patients met our inclusion criteria with 2123 (22.3%) treated with robotic lobectomy and 7389 (77.7%) treated with VATS lobectomy. Comparable R0 resections, 30- and 90-day mortality and 30-day readmission rates were observed for robotic and VATS lobectomy while a higher rate of conversion to thoracotomy was observed for VATS (aOR = 1.99, 95% confidence interval = 1.65, 2.39, P < 0.001). CONCLUSIONS: Our analysis of the National Cancer Database suggests that robotic lobectomy for complex lung resections achieves similar perioperative outcomes and R0 resections as VATS lobectomy with the exception of a lower rate of conversion to thoracotomy.

30 June 2022 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
ZMZaid Muslim
Zaid Muslim
SSStephanie Stroever
Stephanie Stroever
SRSyed S. Razi
Syed S. Razi
KPKostantinos Poulikidis
Kostantinos Poulikidis
MBMirza Zain Baig
Mirza Zain Baig
FBFaiz Y. Bhora
Faiz Y. Bhora

1 February 2022 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
ZMZaid Muslim
Zaid Muslim
MBMirza Zain Baig
Mirza Zain Baig
JWJoanna F. Weber
Joanna F. Weber
CCCliff P. Connery
Cliff P. Connery
FBFaiz Y. Bhora
Faiz Y. Bhora

1 March 2022 in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
Verified
Journal Article
Closed access
ZMZaid Muslim
Zaid Muslim
SSStephanie Stroever
Stephanie Stroever
KPKostantinos Poulikidis
Kostantinos Poulikidis
JWJoanna F. Weber
Joanna F. Weber
CCCliff P. Connery
Cliff P. Connery
FBFaiz Y. Bhora
Faiz Y. Bhora
Objective: We aimed to identify predictors of conversion to thoracotomy and test the hypothesis that conversion is associated with inferior perioperative outcomes in non-small cell lung cancer (NSCLC). Methods: We queried the National Cancer Database for patients with stage I to III NSCLC undergoing minimally invasive surgery (MIS) during 2010 to 2016. We compared clinicopathologic factors between patients undergoing MIS with and without conversion. We fitted multivariable regression models to identify independent predictors of conversion and compare perioperative outcomes between the 2 groups. Results: A rising trend in the use of MIS was accompanied by a declining trend in the rate of conversion to thoracotomy. A total of 11.3% of the 83,219 cases were converted. Conversion was associated with a higher Charlson-Deyo score, squamous histology, nodal involvement, high tumor grade, tumor size ≥5 cm, and a higher T stage ( P < 0.05). Successful MIS without conversion was predicted by advanced age, sublobar resection, robotic approach, and treatment at an academic high-volume facility ( P < 0.05). Conversion was linked to longer hospital stays, higher 30-day and 90-day mortality, and unplanned readmission ( P < 0.05), irrespective of the type of MIS approach. Conclusions: Conversion rates for video-assisted and robot-assisted thoracoscopic surgery have seen a decline in recent years. Irrespective of the type of MIS approach, conversion was associated with inferior perioperative outcomes. The robotic approach and treatment at an academic high-volume facility were associated with a lower likelihood of conversion. Early recognition of the individual risk factors for conversion may help to counsel patients about the likelihood of, and detriments associated with, conversion and ultimately reduce conversion rates.

11 May 2021 in Asian Cardiovascular and Thoracic Annals
Verified
Journal Article
Closed access
PDF file
ZMZaid Muslim
Zaid Muslim
MBMirza Zain Baig
Mirza Zain Baig
JWJoanna F Weber
Joanna F Weber
FDFrank C Detterbeck
Frank C Detterbeck
CCCliff P Connery
Cliff P Connery
FBFaiz Y Bhora
Faiz Y Bhora
Background: The aim of this study is to identify patients with thymoma who should receive post-operative radiotherapy. Methods: The Surveillance, Epidemiology, and End Results database was queried for stage IIB–IV thymoma patients diagnosed during 1988–2015. We analyzed the prognostic implications of various clinical–pathological factors by comparing the outcomes of those who received surgery with and without post-operative radiotherapy. Results: A total of 1120 patients were identified; 62% received post-operative radiotherapy and 38% underwent surgery alone. In a propensity-matched cohort of 812 patients, no survival difference was seen in World Health Organization A, AB, B1, B2, or B3 tumors with the addition of post-operative radiotherapy to surgery (p>0.05). Post-operative radiotherapy also did not improve survival over surgery alone for tumors ≥ or < less than the 4 cm, 7 cm, 10 cm, and 13 cm cutoffs, all p>0.05. Post-operative radiotherapy was an independent, positive prognostic indicator only in the subgroup with stage III disease and in those receiving chemotherapy in addition to post-operative radiotherapy, both p<0.05. Conclusions: Patients with stage III thymoma are most likely to benefit from the addition of post-operative radiotherapy to surgical treatments. Tumor size or World Health Organization histology alone should not be criteria for determining the need for post-operative radiotherapy in locally advanced thymoma. Masaoka–Koga stage, which has traditionally been used to help make such decisions, appears to be the most reliable determinant of the use of post-operative radiotherapy.

19 August 2021 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
ZMZaid Muslim
Zaid Muslim
SSStephanie Stroever
Stephanie Stroever
MBMirza Zain Baig
Mirza Zain Baig
JWJoanna F Weber
Joanna F Weber
CCCliff P Connery
Cliff P Connery
FBFaiz Y Bhora
Faiz Y Bhora
: OBJECTIVES: We aimed to identify patient- and facility-specific predictors of collective adherence to 4 recommended best treatment practices in operable IIIAN2 non-small-cell lung cancer (NSCLC) and test the hypothesis that collective adherence is associated with superior survival.METHODS: We queried the National Cancer Database for clinical stage IIIAN2 NSCLC patients undergoing surgery during 2010–2015. The following best practices were examined: performance of an anatomic resection, performance of an R0 resection, examination of regional lymph nodes and administration of induction therapy. Multivariable regression models were fitted to identify independent predictors of guideline-concordance.RESULTS: We identified 7371 patients undergoing surgical resection for IIIAN2 lung cancer, of whom 90.8% underwent an anatomic resection, 88.2% received an R0 resection, 92.5% underwent a regional lymph node examination, 41.6% received induction therapy and 33.7% received all 4 best practices. Higher income, private insurance and treatment at an academic facility were independently associated with adherence to all 4 best practices (P < 0.01). A lower level of education and residence in a rural county were associated with a lack of adherence (P < 0.05). Adherence to all 4 practices correlated with improved survival (P < 0.01).CONCLUSIONS: National adherence to best treatment practices in operable IIIAN2 lung cancer was variable as evidenced by the majority of patients not receiving recommended induction therapy. Socioeconomic factors and facility type are important determinants of guideline-concordance. Future efforts to improve outcomes should take this into account since guideline concordance, in the form of collective adherence to all 4 best practices, was associated with improved survival.